Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 193,630 shares at $12.94 ($2.5M) on 2024-06-11, disclosed to the SEC on 2024-06-13.
Scheduled sale ($2.5M) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.94 | 96,815 | $1.3M | 50.0% |
| 2 | $12.94 | 96,815 | $1.3M | 50.0% |
| Total | $12.94 avg | 193,630 | $2.5M | 100% |
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |